logo
How Your Skin Changes as You Age—In Your 40s, 50s, 60s and Beyond

How Your Skin Changes as You Age—In Your 40s, 50s, 60s and Beyond

Yahoo07-07-2025
It's no secret that our skin changes as we age. It starts out especially sensitive when we're babies, breaks out during puberty and (sometimes) clears up in our 20s and 30s. According to Dr. Roseanne Paul, a dermatologist at University Hospitals and assistant professor of dermatology at Case Western Reserve University, there are a variety of influencing factors that may result in skin changes as we age, often categorized into intrinsic or extrinsic factors.
'Intrinsic [factors are] part of your genetic predisposition, as well as hormonal changes experienced as we age,' she explains. 'Extrinsic or environmental factors—UV radiation being the most likely and most common—also includes smoking, air pollution, and even [poor] nutrition. More exposure to each of these may result in earlier or more prevalent signs of aging.'
More from Flow Space
The Internet Claims NAD+ Is the Next Big Thing in Longevity. But What Does It Actually Do?
Paul notes that women won't all see the same signs of skin aging in a particular decade of their lives. But here's a general overview of the kinds of changes that tend to occur in our 40s, 50s, 60s and beyond.
By the time you're in your 40s, your skin has likely started to undergo some changes.
'In their 30s to 40s, women often begin to notice early signs of collagen loss, dullness and uneven tone due to a reduction in estrogen and sun exposure,' says Dr. Shamsa Kanwal, a consultant dermatologist. Exposure to sunlight—or tanning bed usage—will prematurely age the skin, making fine lines and wrinkles, brown spots, and broken blood vessels called telangiectasias appear at a younger age, Paul explains.
'In addition to natural aging and sun damage, this is also when signs of perimenopause and declining estrogen levels appear, which can make the skin dull, dry and prone to faster aging,' Dr. Viktoryia Kazlouskaya, a board-certified dermatologist and hair loss expert, says. In your 40s, hormonal shifts accelerate collagen breakdown and reduce skin elasticity, resulting in fine lines, dryness and more noticeable pigmentation, Kanwal explains. 'Many consider hormone replacement treatment (HRT),' Kazlouskaya says.
As far as skin care, 'this is the time to focus on hydration, peptides and sun protection,' Kanwal says.
Additionally, Kazlouskaya says that women should pay closer attention to their overall health.
'One of the most important steps in preventing premature aging is daily sun protection,' Kazlouskaya says. 'Maintaining a healthy lifestyle becomes especially important after 30, when the body starts needing more support. A diet rich in healthy proteins, good sleep and stress management can all have a noticeable impact—not just on how you feel, but even on how you look.'
This is a period when most women experience menopause with lower estrogen levels—meaning drier and duller skin, as well as more noticeable wrinkles and sagging, Kazlouskaya says. Skin also loses collagen quickly during menopause. According to the American Academy of Dermatology Association (AADA), women's skin loses about 30% of its collagen during the first five years of menopause, then 2% every year for the next 20 years.
Decreased levels of estrogen during menopause can also change your skin by impairing your skin's barrier function, reducing sebum production and slowing wound healing, according to Northwestern Medicine. This can also affect the skin on your scalp, which may become drier and thinner, contributing to hair loss.
Along the same lines, postmenopausal skin can become thinner, drier and more prone to bruising or sensitivity, Kanwal says. But there are ways to take care of your skin. 'Gentle but active skin care like ceramides, hyaluronic acid and low-concentration retinoids helps rebuild the barrier,' Kanwal explains. 'Sun protection is essential.'
From your 60s onward, slower cell turnover and fat loss under the skin can lead to sagging and deep wrinkling, Kanwal says. 'In addition to sagging, volume loss and wrinkles, pigmentation issues and dryness also become more prominent,' Kazlouskaya says. Skin can also become thinner and more prone to irritation and itchiness—sometimes as the result of medications, according to the AADA.
Fortunately, there are ways to manage the dryness and irritation, including taking warm (not hot) baths, using a humidifier and applying a creamy, fragrance-free moisturizer within three minutes of bathing and throughout the day, the AADA notes. And don't give up on your skin care routine.
'Skin care should, of course, be continued with sun protection and hydration,' Kazlouskaya says.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Woman diagnosed with brain tumor after routine eye test
Woman diagnosed with brain tumor after routine eye test

New York Post

time18-07-2025

  • New York Post

Woman diagnosed with brain tumor after routine eye test

A woman was diagnosed with a brain tumor after a routine eye test and given a second blow when doctors discovered she also had breast cancer four months later. Elizabeth Craig, 55, had gone for a standard appointment at her local Specsavers in January 2022 when her optician noticed something unusual during the examination. She was diagnosed with a meningioma after an MRI scan revealed a brain tumor pressing on her optic nerve. At a follow-up appointment four months later, doctors spotted a suspicious nodule in Elizabeth's right breast, and she was diagnosed with breast cancer. 6 Elizabeth Craig, 55, had gone for a standard appointment at her local Specsavers in January 2022 when her optician noticed something unusual during the examination. Brain Tumour Research / SWNS She had a mastectomy and lymph node removal, and paused treatment to get married in 2024, before undergoing brain surgery in February 2025 to remove her brain tumor. Elizabeth, from Corby, Northamptonshire, said: 'When they told me I had a tumor behind my eye, I felt completely overwhelmed. It didn't seem real. I had gone in expecting to get some new glasses, and within days I was facing conversations about brain surgery. 'I immediately assumed it was cancer, and my mind went to the worst-case scenario. 6 Craig was diagnosed with a meningioma after an MRI scan revealed a brain tumor pressing on her optic nerve. Brain Tumour Research / SWNS 'Getting two diagnoses like that, so close together, was a lot to process. It felt like my life was spiralling.' Elizabeth was referred to Kettering General Hospital after the optician found it unusual that she couldn't see out of her left eye but had no visible problems with the eye itself. She was diagnosed in January 2022 and had further testing done – such as blood tests. 6 At a follow-up appointment four months later, doctors spotted a suspicious nodule in Elizabeth's right breast, and she was diagnosed with breast cancer. Brain Tumour Research / SWNS In May 2022, she had a follow-up CT scan at John Radcliffe Hospital and was referred to the breast clinic, and diagnosed with breast cancer in May 2022. She said, 'I didn't tell many people at first about this terrifying news. 'I had only been with my partner Paul for six months at the time, and I didn't want to burden him. But he was amazing and supported me every step of the way.' 6 'I had only been with my partner Paul for six months at the time, and I didn't want to burden him. But he was amazing and supported me every step of the way,' Elizabeth said. Brain Tumour Research / SWNS Elizabeth had a mastectomy and lymph node removal later that year, followed by radiotherapy in June 2023. Once she was given the all-clear from breast cancer, she returned to John Radcliffe Hospital to discuss surgery for the brain tumor. She chose to postpone the operation so she and Paul could get married in June 2024. 6 Once she was given the all-clear from breast cancer, she returned to John Radcliffe Hospital to discuss surgery for the brain tumor. Brain Tumour Research / SWNS In February 2025, Elizabeth underwent a complex nine-hour procedure to successfully remove most of the brain tumor, which was later confirmed as non-cancerous. Now, Elizabeth is taking part in Brain Tumor Research's 88 Squats a Day in July challenge, aiming to complete 88 squats each day throughout the month. The total number of squats by the end of July symbolically represents the $3,685 (£2,740) it costs to fund a single day of research at one of the charity's Centres of Excellence. Elizabeth said, 'Taking on this challenge is deeply personal. Until it happened to me, I didn't realise how underfunded research into brain tumors is, even though they kill more children and adults under the age of 40 than any other cancer. 6 Brain Tumour Research / SWNS 'I want to do what I can to raise awareness and help make a difference. Even though I'm still recovering, I feel ready to give something back.' Ashley McWilliams, community development manager at Brain Tumor Research, said: 'Elizabeth's story highlights how a simple eye test can lead to lifesaving discoveries. Her courage in facing not just one but two major diagnoses and her determination to raise awareness through this challenge is inspiring. We're so grateful for her support and wish her luck for the squat challenge.' People can go here to support Elizabeth's 88 squats challenge.

Which IV Iron Formulation Is Right for Your Patient?
Which IV Iron Formulation Is Right for Your Patient?

Medscape

time17-07-2025

  • Medscape

Which IV Iron Formulation Is Right for Your Patient?

This transcript has been edited for clarity. Matthew F. Watto, MD: Welcome back to The Curbsiders . I'm Dr Matthew Frank Watto here with my great friend and America's primary care physician, Dr Paul Nelson Williams. Paul, are you a fan of iron? Paul N. Williams, MD: You know it! That's why we've done about 12 episodes on iron at this point. Watto: As in, pumping iron? Williams: Sure, look at me — I'm jacked! Watto: Paul, we had a great guest on this episode, Dr Tom DeLoughery (@Bloodman). He was a great guest and a hilarious guy. Let's talk about it, Paul: microcytic anemia. I know iron deficiency can cause that, but what else can cause microcytic anemia? Williams: I appreciated the breakdown of this episode. Our guest says that there are four big things that can cause microcytic anemia that you need to know about. One is iron deficiency; that is far and away probably the most common one. Then there is anemia of chronic disease, which I don't think we think about as much. If the mean corpuscular volume (MCV) is less than 70 fL, it's probably not anemia of chronic disease, but anemia of chronic disease can cause microcytic anemia. The next is thalassemia, which is probably more common than we give it credit for. The last one is sideroblastic anemia, which is something you're probably not going to be diagnosing in adulthood and is an uncommon cause. So really, if you consider those first three causes — especially with the framework that he gives — it can be pretty easy to distinguish between iron deficiency, anemia of chronic disease, and thalassemia. That's what you need to figure out before we start just giving iron willy-nilly. Watto: I don't think I've ever even seen sideroblastic anemia in a chart outside of an exam setting. I feel like you're more likely to see consumption written in the chart than sideroblastic anemia! Williams: Yeah, I feel like it's the type of disorder I would've been quizzed about during floors a million years ago but not something I've actually seen — ever, I don't think. Watto: Now, Paul, when I'm working up anemia, I like to look at all the things: red cell distribution width (RDW), total iron binding capacity (TIBC), iron. Is that a waste of my time, Paul? Williams: I would never call it a waste of your time. I'm sure it's of academic interest, but both our guest and I, in my own practice, don't spend too much time dwelling on those when we're chasing down microcytic anemia. Dr DeLoughery does not look at the TIBC all that often. It really is the ferritin, the MCV, and the hemoglobin that are the big-ticket items when you're working up iron deficiency anemia. The rest is all largely window dressing, according to him. I feel good about that, because I don't like sweating out equations and working through those things. Watto: Okay, so we're looking for low hemoglobin. An MCV of less than 80 fL or so is usually considered microcytic in most labs. Now, the ferritin cutoff was an interesting one. Some labs might say 15 ug/dL or less. Some labs say 30 ug/dL or less. Dr DeLoughery recommends a ferritin cutoff of 30 ug/dL or less. But for most patients, we're usually going to treat to at least a ferritin of 50 ug/dL, because if patients are fatigued from iron efficiency, they usually feel better once we achieve a ferritin level of 50 ug/dL or higher. But we should remember that the reason why the lab cutoffs are lower is because they're looking at population average. And because iron deficiency anemia is so common and a large portion of our population has iron deficiency, the average ferritin values are lower than what ideal, healthy levels should be. If you just measured ferritin among patients with normal iron stores, the ferritin cutoff would be much higher. Paul, what do you think about these specific ferritin cutoffs that he recommended? Have you heard about that before? Because when I was prepping for this, I was unfamiliar with those cutoff values and what values we should consider when determining treatment. Williams: Do you mean in terms of when symptoms actually occur? Watto: Yes. For example, he said that for patients experiencing fatigue, you want to get the ferritin to 50 ug/dL or higher. And then he mentioned two other symptoms: restless legs and hair loss. Williams: Yeah, and for restless legs, you need to get ferritin above 75 ug/dL to actually achieve adequate iron levels in the brain. And then for hair loss, your goal is to get to at least 100 ug/dL to reverse the hair loss, if iron deficiency is indeed the contributing cause and not just getting old. Watto: For a lot of patients, they might need IV iron to get their levels up that much. Dr DeLoughery checks levels every 3 months or so, for the most part, because you want to give it some time to re-equilibrate after you give the iron. Now, Paul, when I'm trying to get those ferritin levels up, I usually tell my patients to take their iron with coffee and tea. Is that a bad thing to do? Williams: Bad news for us, Matt, and for the rest of the world. But yes, unfortunately coffee and tea can reduce your absorption of iron, so you should probably avoid drinking either of those within an hour of taking your oral iron supplementation. If you want to boost absorption, you can take your supplement with meat protein. So, substitute steak instead of your coffee, I guess? There's also always an ongoing debate and discussion about vitamin C potentially increasing iron absorption. Our guest, Dr DeLoughery, is a fan of it, but I think the jury is still largely out as far as that goes. Watto: And it seems like coffee and tea really impact iron absorption. I think he said it's like 80% or 90% decreased absorption; it was very significant. Williams: I know we have a long history of championing coffee in terms of being good for everything, but this might be the one instance where you don't necessarily have to avoid it; you just have to delay it. Watto: Yeah, exactly. Just make sure to avoid taking your iron within an hour (on either side) of coffee consumption and you're good to go. Williams: That would still be a real problem for me. Watto: When you have a continuous IV of coffee, that doesn't give you much time to get the iron in, Paul! Williams: Yep, and speaking of IVs… Watto: I just wanted to quickly shout out some IV iron formulations. The ones that I've had more experience with are IV iron sucrose and ferric gluconate. The reason I'm most familiar with those are because they are the cheaper formulations and they happen to have been on formulary. However, those are not the best formulations if you have the options, because the newer formulations can be given quicker and in a single dose or two doses compared to the ones I just mentioned, which need 4-8 weeks of weekly IV doses to administer the amount we'd like. Dr DeLoughery liked low-molecular-weight iron dextran because it comes in 1000 mg and you can give it within an hour. This is the formulation we discussed with Dr Auerbach back in 2018. Dr Auerbach told us that when you give low-molecular-weight iron dextran to your classic anemia patient — let's say a young woman with iron deficiency who has a hemoglobin of 7 g/dL — they'll start to feel better before the iron is even done infusing! It's pretty well proven. Williams: Yeah, patients will experience a reduction in ice craving as they're receiving the treatment, which is wild. Watto: Paul, why would it be a bad idea if I gave someone ferumoxytol — which comes in a dose of 510 mg and you have to give it twice — before I was going to, say, send them for an MRI? Williams: In that specific circumstance, it's important to know that ferumoxytol can impact MRIs because it acts like contrast. And that effect can persist for 3 months after the infusion itself, so you can significantly alter the results of your MRI and make the imaging hard to interpret if you don't space those things out. That would be one reason to avoid ferumoxytol, if you're planning on upcoming imaging. Watto: The other IV iron formulation that I was really excited to try out was ferric carboxymaltose. It comes in at 750 mg per dose, so you can give one or two doses depending on the severity of iron deficiency. But why might that be a bad idea? Williams: It's nice of you to ask. So, there's the possibility of symptomatic hypophosphatemia with ferric carboxymaltose, which, again, is wild. It's always a delightful surprise to discover the terrible things you could potentially do — even though they are, by and large, safe. Watto: The hypophosphatemia sounds bad because it sounds like if you try to give the patient phosphate, it gets worse because the body just accelerates how quickly it's getting rid of phosphorus. It's bad, Paul. So, I will not be giving that one. Ever. Williams: Yeah, I don't think I've ever ordered that one happily. I would probably avoid it if I had better options available.

Researchers try new ways of preserving more hearts for transplants
Researchers try new ways of preserving more hearts for transplants

Washington Post

time16-07-2025

  • Washington Post

Researchers try new ways of preserving more hearts for transplants

WASHINGTON — Two university hospitals are pioneering new ways to expand lifesaving heart transplants for adults and babies — advances that could help recover would-be heart donations that too often go unused. The new research aims to overcome barriers for using organs from someone who dies when their heart stops. Called DCD, or donation after circulatory death , it involves a controversial recovery technique or the use of expensive machines.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store